ArticleAntibiotics (Basel, Switzerland)2021
Dissemination of Carbapenemases (OXA-48, NDM and VIM) Producing
Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Microbiological profiles of Gram-negative bacteria isolated from respiratory samples of mechanically ventilated patients at a tertiary Moroccan hospital.IJID regions · 2026Article
- Molecular characterization of virulence and resistance determinants in clinical Pseudomonas aeruginosa isolates: a cross-sectional analysis of virulence-resistance associations.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Evaluation of susceptibility to colistin, fosfomycin and mecillinam in carbapenemase-producing Enterobacterales isolated in Marrakech in 2023.Iranian journal of microbiology · 2026Article
- Epidemiological burden of multidrug-resistant bacteria and carbapenemases in Northern Morocco: a one-year observational study.BMC infectious diseases · 2026Observational
- Article
- Global High-RiskInternational journal of microbiology · 2026Article
- Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon.Frontiers in cellular and infection microbiology · 2026Article
- Biofilm-producing and carbapenems-resistant Escherichia coli nosocomial uropathogens: a cross-sectional study.International microbiology : the official journal of the Spanish Society for Microbiology · 2024Article
- Dynamics of antimicrobial resistance and susceptibility profile in full-scale hospital wastewater treatment plants.Water science and technology : a journal of the International Association on Water Pollution Research · 2024Article
- Emergence of Carbapenem-Resistant Gram-Negative Isolates in Hospital Settings in Djibouti.Antibiotics (Basel, Switzerland) · 2023Article
- Genomic characterization of two carbapenem-resistantFrontiers in cellular and infection microbiology · 2023Article
- Predominance of OXA-48 Carbapenemase-Producing Enterobacterales in a Moroccan Hospital.International journal of microbiology · 2023Article
- First Emergence of NDM-5 and OqxAB Efflux Pumps Among Multidrug-ResistantInfection and drug resistance · 2023Article
- Carbapenem-Resistant Organisms Isolated in Surgical Site Infections in Benin: A Public Health Problem.Tropical medicine and infectious disease · 2022Article
- Occurrence and Characteristics of Carbapenem-ResistantPathogens (Basel, Switzerland) · 2022Article
- Antimicrobial resistance among GLASS pathogens in Morocco: an epidemiological scoping review.BMC infectious diseases · 2022Article
- Phenotype-genotype correlations among carbapenem-resistant Enterobacterales recovered from four Egyptian hospitals with the report of SPM carbapenemase.Antimicrobial resistance and infection control · 2022Article
- Co-Production of NDM-1 and OXA-10 β-Lactamase inInfection and drug resistance · 2022Article
- Clinical carbapenem-resistantFrontiers in cellular and infection microbiology · 2022Article
- Co-occurrence of genes encoding carbapenem resistance and aminoglycoside resistance in clinical isolates of Enterobacterales.Drug target insightsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence and spread of carbapenem-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.